Metabolic impact of low dose IL-2 therapy for primary Sjögren's Syndrome in a double-blind, randomized clinical trial. - Feng, Ruiling; Xiao, Xian; Wang, Yifan; Huang, Bo; Chen, Jiali; Cheng, Gong; Jin, Yuebo (Clinical Rheumatology, 2024)